Potent inhibitory effects of steroids in an in vitro model of angiogenesis

Journal of Endocrinology

Volumn 150, Issue 3, 1996, Pages 457-464

  Jaggers, D C ^c   Collins, W P ^b   Milligan, S R ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; ESTRADIOL; ESTRIOL; ESTRONE; HYDROCORTISONE; HYDROCORTISONE DERIVATIVE; HYDROXYPROGESTERONE; MEDROXYPROGESTERONE ACETATE; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; PROGESTERONE;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; MICROVASCULATURE; NONHUMAN; OVARY FOLLICLE MATURATION; PRIORITY JOURNAL; RAT;

EID: 0029783470     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1500457     Document Type: Article

References (28)

1. Andersen CY 1990 Levels of steroid-binding proteins and steroids in human preovulatory follicle fluid and serum as predictors of success in in vitro fertilization-embryo transfer treatment. Journal of Clinical Endocrinology and Metabolism 71 1375-1381.
2. Ashino-Fuse H, Takano Y, Oikawa T, Shimamura M & Iwaguchi T 1989 Medroxyprogesterone acetate, an anti-cancer and anti-angiogenic steroid, inhibits the plasminogen activator in bovine endothelial cells. International Journal of Cancer 44 859-864.
3. Berthois Y, Katzenellenbogen JA & Katzenellenbogen BS 1986 Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proceedings of the National Academy of Sciences of the USA 83 2496-2500.
4. Ben-Rafael Z, Mastroianni L, Meloni F, Lee MS & Flickinger GL 1986 Total estradiol, free estradiol, sex hormone-binding globulin and the fraction of estradiol bound to sex hormone-binding globulin in human follicular fluid. Journal of Clinical Endocrinology and Metabolism 63 1106-1111.
5. Bindal RD, Carlson KE, Katzenellenbogen BS & Katzenellenbogen JA 1988 Lipophillic impurities, not phenolsulfonaphthalein, account for the estrogenic activity in commercial preparations of phenol red. Journal of Steroid Biochemistry 31 287-293.
6. Blei F, Wilson L, Mignatti P & Rifkin DB 1993 Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis. Journal of Cellular Physiology 155 568-578.
7. Bomsel-Helmreich O, Gougeon A, Thebault A, Saltarelli D, Milgrom E, Frydman R & Papiernik E 1979 Healthy and atretic human follicles in the preovulatory phase: differences in evolution of follicular morphology and steroid content of follicular fluid. Journal of Clinical Endocrinology and Metabolism 48 686-694.
8. Brandi ML, Crescioli C, Tanini A, Frediani U, Agnusdei D & Gennari G 1993 Bone endothelial cells as estrogen targets. Calcified Tissue International 53 312-317.
9. Crum R, Szabo S & Folkman J 1985 A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment. Science 230 1375-1378.
10. Diglio GA, Grammas P, Giacomelli F & Wiener J 1989 Angiogenesis in rat aorta ring explant cultures. Laboratory Investigation 60 523-531.
11. Fotsis T, Zhang Y, Pepper M, Adlercreutz H, Montesano R, Nawroth PP & Schweigerer L 1994 The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature 368 237-239.
12. Fowler RE, Edwards RG, Walters DE, Chan STH & Steptoe PC 1978 Steroidogenesis in preovulatory follicles of patients given human menopausal and chorionic gonadotrophins as judged by the radioimmunassay of steroids in follicular fluid. Journal of Endocrinology 77 161-169.
13. Gagliardi A & Collins DG 1993 Inhibition of angiogenesis by antiestrogens. Cancer Research 53 533-535.
14. Gross J, Azizkhan RG, Biswas C, Bruns RR, Hsieh DSP & Folkman J 1981 Inhibition of tumour growth, vascularisation and collagenolysis in the rabbit cornea by medroxyprogesterone. Proceedings of the National Academy of Sciences of the USA 78 1176-1180.
15. Ingber DE, Madri JA & Folkman J 1986 A possible mechanism for inhibition of angiogenesis by angiostatic steroids: induction of capillary basement membrane dissolution. Endocrinology 119 1768-1775.
16. Jaggers DC & Milligan SR 1993 Is oestradiol an angiostatic steroid? Journal of Reproduction and Fertility Abstract 11 17.
17. Koos, RD 1989 Potential relevance of angiogenic factors to ovarian physiology. Seminars in Reproductive Endocrinology 7, 29-40.
18. Koos RD 1993 Ovarian angiogenesis. In The Ovary, pp 433-453. Eds EY Adashi & PCK Leung. New York: Raven Press.
19. Lenton EA, King H, Thomas EJ, Smith SK, MacLachlan RI, MacNeil S & Cooke ID 1988 The endocrine environment of the human oocyte. Journal of Reproduction and Fertility 82 827-841.
20. McClure N, Macpherson AM, Abberton KM, Healy DL & Rogers PAW 1993 Human follicular fluid maturity and endothelial cell mitogenesis. Human Reproduction 8 1564-1569.
21. McClure N, MacPherson AM, Healy DL, Wreford N & Rogers PAW 1994 An immunohistochemical study of the vascularization of the human Graafian follicle. Human Reproduction 9 1401-1405.
22. Morales DE, McGowan KA, Grant DS, Maheshwari S, Bhartiya D, Cid, MC, Kleinman HK & Schnaper W 1995 Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and a murine model. Circulation 91 755-763.
23. Nicosia RF & Ottinetti A 1990 Growth of microvessels in serum-tree matrix culture of rat aorta. Laboratory Investigation 63 115-122.
24. Nicosia RF, Bonanno E & Smith M 1993 Fibronectin promotes the elongation of microvessels during angiogenesis in vitro. Journal of Cell Physiology 154 654-661.
25. Wakeling AE 1993 Are breast tumours resistant to tamoxifen also resistant to pure antioestrogens? Journal of Steroid Biochemistry and Molecular Biology 47 107-114.
26. Wiseman H, Cannon M, Armtein HRV & Halliwell B 1990 Mechanism of inhibition of lipid peroxidation by tamoxifen and 4-hydroxy tamoxifen introduced into liposomes. Federation of European Biochemical Societies 274 107-110.
27. Wiseman H, Quinn P & Halliwell B 1993 Tamoxifen and related compounds decrease membrane fluidity in liposomes Federation of European Biochemical Societies 330 53-56.
28. Yamamoto T, Terada N, Nishizawa Y & Petrow V 1994 Angiostatic activities of medroxyprogesterone acetate and its analogues. International Journal of Cancer 56 393-399.